fbpx
Sign up now!
Don't show this again
Download the report!Continue to Site >
or wait 7 secs

Thank you for confirming your subscription!

(And remember, if ever you want to change your email preferences or unsubscribe, just click on the links at the bottom of any email.)

We’re glad you’re enjoying Pig Health Today.
Access is free but you’ll need to register to view more content.
Already registered? Sign In
Tap to download the app
X
Share
X

REPORTS

Collect articles and features into your own report to read later, print or share with others

Create a New Report

Favorites

Read Later

Create a new report

Report title (required) Brief description (optional)
CREATE
X
NEXT
PORK POULTRY
follow us


You must be logged in to edit your profile.

Favorites Read Later My Reports PHT Special Reports
Pig Health Today is equipped with some amazing (and free) tools for organizing and sharing content, as well as creating your own magazines and special reports. To access them, please register today.
Sponsored by Zoetis

Pig Health Today | Sponsored by Zoetis

.

Tag Archive: , , , , , , ,

Pigs fed BMD® gain more weight faster despite stress in controlled studies

DISCOVERIES, Issue 15: Grower pigs fed BMD® gained weight faster and had better feed efficiency compared to controls despite exposure to commonly encountered production stressors, studies show.

Aureomycin® granular premix retained higher potency than Terramycin® meal premix in study

DISCOVERIES, Issue 2: The particle size and distribution of a medicated-feed premix can dramatically affect how much active ingredient ends up in a pig’s digestive tract for disease treatment or...

Two-dose Fostera® Gold PCV MH regimen yields performance advantages

DISCOVERIES, Issue 16: Pigs in a study that received two doses of Fostera® Gold PCV MH, the new Zoetis vaccine for PCV2 and M. hyo, had numerically fewer reactions, less morbidity, less mortality.

M. hyo treatment with Draxxin® plays important role in SRD management

DISCOVERIES, Issue 14: Pigs treated for Mycoplasma hyopneumoniae (M. hyo) with a single dose of the injectable antimicrobial Draxxin® (tulathromycin) had significantly better average daily gain and...

Field studies demonstrate safety of Fostera® Gold PCV MH vaccine

DISCOVERIES, Issue 5: Fostera® Gold PCV MH, the new inactivated vaccine from Zoetis developed to provide the broadest protection available against porcine circovirus type 2 (PCV2), has been...

Evolution of PCV2 virus, need for broader coverage spurred development of Fostera® Gold PCV MH

DISCOVERIES, Issue 7: Compelling scientific evidence indicating the need for an updated porcine circovirus type 2 (PCV2) vaccine was the driving force behind the development of Fostera® Gold PCV...

Fostera® Gold PCV MH protects pigs against PCV2a, PCV2b and M. hyo for at least 23 weeks

DISCOVERIES, Issue 8: Fostera® Gold PCV MH is the only USDA-licensed vaccine that protects pigs against porcine circovirus (PCV) type 2a, PCV2b and M. hyo for at least 23 weeks.

New PCV2 vaccine for swine elicits strong cell-mediated immune response

DISCOVERIES, Issue 9: A new porcine circovirus type 2 (PCV2) vaccine from Zoetis produces a robust and lasting cell-mediated immune response.

One dose of Draxxin® at weaning for SRD yields multiple benefit

DISCOVERIES, Issue 13: Pigs from herds with a natural outbreak of swine respiratory disease (SRD) had significantly better outcomes when they received just one injection of Draxxin® (tulathromycin)...

Antimicrobial’s unique attributes explain efficacy against key SRD pathogens

DISCOVERIES, Issue 12: The efficacy of Draxxin® (tulathromycin) against key swine respiratory disease (SRD) pathogens is largely due to the antimicrobial’s ability to reach and sustain high...

Long duration of antibiotic helps improve clinical outcome after APP challenge

DISCOVERIES, Issue 10: Pigs treated with one intramuscular dose of Draxxin® (tulathromycin) and then challenged with a virulent strain of APP had significantly reduced mortality and lung lesions...

Five-site study demonstrates efficacy of Draxxin® for SRD

DISCOVERIES, Issue 11: A five-site study of pigs with swine respiratory disease (SRD) demonstrates that one dose of Draxxin® (tulathromycin) not only lowers mortality, it can significantly improve...

Chimera technology offers better path to protection for PCV2

DISCOVERIES, Issue 6: When PCV2 first became a problem in US swine herds, scientists looked at taking the immunogenic capsid gene from PCV2 and cloning it into the backbone of nonpathogenic PCV type...

Epitope-comparison study illustrates broad coverage of Fostera Gold® PCV MH against PCV2 viruses

DISCOVERIES, Issue 4: Swine disease specialists speculated that a PCV2 vaccine containing two genotypes — PCV2a and PCV2b — would significantly improve the coverage provided against PCV2...

Large field trial showed Fostera Gold® PCV MH was effective against prevalent PCV2d genotype

DISCOVERIES, Issue 3: A large, commercial field trial conducted with Fostera® Gold PCV MH showed it was also effective against PCV2d, the most prevalent genotype of the virus circulating among US...

Pigs vaccinated with Fostera®PCV MH equally protected, weighed nearly 8 pounds more in large comparison trial

DISCOVERIES, Issue 1: Pigs vaccinated with Fostera® PCV MH were equally protected against porcine circovirus (PCV) type 2d as well as Mycoplasma hyopneumoniae (M. hyo) and weighed 7.78 pounds more...


You must be logged in to edit your profile.

Google Translate is provided on this website as a reference tool. However, Poultry Health Today and its sponsor and affiliates do not guarantee in any way the accuracy of the translated content and are not responsible for any event resulting from the use of the translation provided by Google. By choosing a language other than English from the Google Translate menu, the user agrees to withhold all liability and/or damage that may occur to the user by depending on or using the translation by Google.